Hochschulschrift
Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity
- Weitere Titel
-
Fenretinide sensibilisiert Multidrug-resistente Neuroblastom Zellen für Antikörper-unabhängige und ch14.18-vermittelte Zytotoxizität
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Medizinische Fakultät Charité - Universitätsmedizin Berlin, Diss., 2012
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Medizinische Fakultät Charité - Universitätsmedizin Berlin
- (wann)
-
2012
- Urheber
-
Shibina, Anastasia
- URN
-
urn:nbn:de:kobv:188-fudissthesis000000039615-0
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Shibina, Anastasia
- Medizinische Fakultät Charité - Universitätsmedizin Berlin
Entstanden
- 2012
Ähnliche Objekte (12)
Aurora kinases as targets in drug-resistant neuroblastoma cells
Heterogeneity of metastogenic neuroblastoma cells
Defining tumor-initiating cells (stem cells) in chemoresistant neuroblastoma cell lines
CD57high neuroblastoma cells have characteristics of tumor-initiating cells
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection
Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
Aurora kinases as targets in drug-resistant neuroblastoma cells
Heterogeneity of metastogenic neuroblastoma cells
Defining tumor-initiating cells (stem cells) in chemoresistant neuroblastoma cell lines
CD57high neuroblastoma cells have characteristics of tumor-initiating cells
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection
Gas Plasma-Treated Prostate Cancer Cells Augment Myeloid Cell Activity and Cytotoxicity
Aurora kinases as targets in drug-resistant neuroblastoma cells
Heterogeneity of metastogenic neuroblastoma cells
Defining tumor-initiating cells (stem cells) in chemoresistant neuroblastoma cell lines
CD57high neuroblastoma cells have characteristics of tumor-initiating cells
Treatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Testing of the survivin suppressant YM155 in a large panel of drug-resistant neuroblastoma cell lines
Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells
Molecular epidemiology of multidrug-resistant zoonotic pathogens
Nanocatalytic materials against multidrug-resistant bacterial infection